Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.65 |
| ▸ | DRD2 | P14416 | 6/20 | 0.62 |
| ▸ | DRD1 | P21728 | 6/20 | 0.62 |
| ▸ | DRD4 | P21917 | 5/20 | 0.62 |
| ▸ | DRD5 | P21918 | 5/20 | 0.62 |
| ▸ | DRD3 | P35462 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.48 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | ANPEP | P15144 | 1/20 | 0.44 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.43 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.43 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | PNMT | P11086 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33555 | 0.89 | — | — | |
| SCHEMBL4465325 | 0.89 | TSHR (0.71) | CYP2A6DRD2DRD1DRD4DRD5 | |
| SCHEMBL34906 | 0.89 | — | — | |
| SCHEMBL29351986 | 0.89 | — | — | |
| SCHEMBL1525601 | 0.89 | — | — | |
| SCHEMBL22081972 | 0.89 | CYP1A2 (0.62) | CYP2A6DRD2DRD1DRD4DRD5 | |
| SCHEMBL109650 | 0.89 | CYP1A2 (0.62) | CYP2A6DRD2DRD1DRD4DRD5 | |
| SCHEMBL29881712 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL4314909 | 0.85 | — | — | |
| Water SCHEMBL2528680 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026042047-A1 | COMPOSITIONS AND ARTICLES COMPRISING REVERSIBLE COMPLEXES OF CROSSLINKED CARRAGEENAN | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| EP-4608895-A1 | HIGH TEMPERATURE DIELECTRIC POLYMERS AND FILMS | The Scripps Research Institute (US) | 2025-09-03 | — | — | EP | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250034080-A1 | CATIONIC LIPID CONTAINING SIDE-CHAIN FUNCTIONAL GROUPS AND APPLICATION THEREOF | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2025-01-30 | — | — | US | claimed |
| EP-4458805-A1 | CATIONIC LIPID CONTAINING FUNCTIONAL GROUP ON SIDE CHAIN, AND USE THEREOF | Xiamen Sinopeg Biotech Co., Ltd. (CN) | 2024-11-06 | — | — | EP | claimed |
| CN-118344332-A | New synthesis method of dibenzosuberane skeleton | 西南交通大学 | 2024-07-16 | — | — | CN | claimed |
| WO-2024091675-A1 | HIGH TEMPERATURE DIELECTRIC POLYMERS AND FILMS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-05-02 | — | — | WO | claimed |
| WO-2024091684-A1 | POLYSULFATE AND POLYSULFONATE POLYMERS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-05-02 | — | — | WO | claimed |
| CN-117377651-A | Cationic lipid with side chain containing functional groups and application thereof | 厦门赛诺邦格生物科技股份有限公司 | 2024-01-09 | — | — | CN | claimed |
| WO-2023126006-A1 | CATIONIC LIPID CONTAINING FUNCTIONAL GROUP ON SIDE CHAIN, AND USE THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2023-07-06 | — | — | WO | claimed |
| WO-1999031081-A1 | PH SENSITIVE PHOTOCHROMIC DYES | JAMES ROBINSON LIMITED (GB) | 1999-06-24 | — | — | WO | claimed |
| WO-1999008112-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-02-18 | — | — | WO | claimed |
| WO-1998041523-A1 | PROCESS FOR PREPARING DIBENZO-1-CARBOXAMIDO-1,4-AZABICYCLO(3.2.1.) OCTANES | NEUROGEN CORPORATION (US) | 1998-09-24 | — | — | WO | claimed |
| EP-0839026-A1 | POLYETHER BLOCK COPOLYMER MICELLAR COMPOSITIONS FOR TARGETING BIOLOGICAL AGENTS | SUPRATEK PHARMA, INC. (CA) | 1998-05-06 | — | — | EP | claimed |
| US-5663030-A | A PHENYL OR NORBORNANE DERIVATIVE AS AN ADDITIVE TO REDUCE HEAT AND ENERGY REQUIRED TO FUSE THE TONER AND TO REDUCE JAMMING OF THE EQUIPMENT | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| WO-1996040056-A1 | POLYETHER BLOCK COPOLYMER MICELLAR COMPOSITIONS FOR TARGETING BIOLOGICAL AGENTS | SUPRATEK PHARMA INC. (CA) | 1996-12-19 | — | — | WO | claimed |
| US-5506231-A | ADMINISTERING AN ANTAGONIST OF EXCITATORY AMINO ACIDS TO REDUCE CENTRAL NERVOUS SYSTEM DISORDER CAUSED BY HUMAN IMMUNODEFICIENCY VIRUS INFECTION | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1996-04-09 | — | — | US | claimed |
| EP-0185988-B1 | 10,11-Dihydro-5H-dibenzo[a,d]cycloheptadiene derivatives, their preparation and use | BASF Aktiengesellschaft (DE) | 1988-03-16 | — | — | EP | claimed |
| US-4670435-A | 10,11-dihydro-5H-dibenzo[a,d]cycloheptadiene derivatives in a method for treating cardiac arrhythmia | BASF AKTIENGESELLSCHAFT (DE) | 1987-06-02 | — | — | US | claimed |
| US-3960872-A | ANTIHISTAMINES, APPETITE STIMULANT | MERCK & CO., INC. (US) | 1976-06-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250034080-A1 | CATIONIC LIPID CONTAINING SIDE-CHAIN FUNCTIONAL GROUPS AND APPLICATION THEREOF | PHOSPHO1, LIPA, SLC7A1 | CYP2A6 3928/4885DRD2 2491/4885DRD1 1463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.